Provexis plc (PXS.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Provexis plc
Address
2 Blagrave Street
Reading, RG1 1AZ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 7490 391 888
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2
First IPO Date
June 28, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Ian Ford | Chief Executive Officer, Chief Financial Officer, Company Secretary & Executive Director | 185,609 | 1965 |
| Niamh Ann O'Kennedy | Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director | 39,732 | 1973 |
| Asim K. Duttaroy FICN | Consultant & Member of Scientific Advisory Board | 0 | N/A |
Description
Operating globally, Provexis plc, along with its associated companies, specializes in the creation, licensing, and commercialization of functional foods, medical nutritional products, and dietary supplements. A key offering is Fruitflow, a unique tomato extract designed to reduce the tendency for abnormal blood clot formation, which is linked to severe cardiovascular conditions such as heart attacks and strokes. This versatile extract is available in syrup and powder formats for integration into various food and beverage items, as well as dietary supplements. The company also provides Fruitflow + Omega-3, a capsule-based supplement aimed at fostering healthy blood circulation and supporting normal cardiac function. Provexis plc holds a strategic collaboration agreement with By-Health Co., Ltd. Its products are distributed through both physical retail channels and digital online platforms. Founded in 1999, Provexis plc has its headquarters situated in Reading, United Kingdom.